Clinical Trials Browser

Terminated × Brentuximab Vedotin × 1 year × Clear all

NCT03646123 2025-08-28

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Phase 2 Terminated

255 enrolled 29 charts

Hodgkin Disease